WHO Drug Information
Volume 22, Number 1, 2008
Our first issue of WHO DRUG INFORMATION for 2008 opens with a feature article on new regulatory systems being devised to address the growing number of biosimilar products entering the market.
Pharmacovigilance Focus presents a report from the Annual Meeting of the WHO Programme for International Drug Monitoring held in Buenos Aires, Argentina, and proposes some interesting solutions for database reporting of adverse drug reactions.
The Current Topics section provides information on new licensing mechanisms for vaccines in the Americas, a report on counterfeit artesunate in South-east Asia and the ort of a meeting on medicines pricing held with Ministers from the Eastern Mediterranean countries.
The section on Safety and Efficacy gives the latest information on signals and reports of adverse drug reactions, with other news from around the world, including labeling changes. This is complemented by Regulatory Action and News which provides the most recent developments from regulatory authorities, and particularly those having an impact on decision-taking.
Several informational documents and events are reviewed and the journal concludes with Recommended list number 59 of International Nonproprietary Names (INN).